-
Professor Tongyu Lin: Scaling New Heights in Precision Diagnosis and Treatment of Lymphoma | 2024 Nanjing Lymphoma Forum
To further explore the advances in clinical and pathological diagnosis, treatment, and translational medicine research in lymphoma, the “2024 Nanjing Lymphoma Forum” was held in Nanjing from May 11-12, 2024. At the forum, Professor Tongyu Lin from Sun Yat-sen University Cancer Center and Sichuan Cancer Hospital delivered an academic report titled “Progress in Lymphoma Diagnosis…
-
EBMT Interview with Professor Peiyan Kong: New Challenges in Hematologic Oncology Diagnosis and Treatment Brought by Aging
As the population continues to age, the incidence of hematologic malignancies in the elderly has been rising, presenting new challenges for clinical treatment. From April 14 to 17, 2024, the 50th European Society for Blood and Marrow Transplantation (EBMT) Annual Meeting was held in Glasgow, UK. The conference focused on the latest advancements in stem…
-
2024 EBMT Review | Professor Jun Ma: Study on Cytokine Release Syndrome and Neurotoxicity Characteristics Following Bispecific Antibody and CAR-T Cell
From April 14 to 17, 2024, the 50th European Society for Blood and Marrow Transplantation (EBMT) Annual Meeting was grandly held in Glasgow, UK, a city renowned for its historical significance. This year marks the 50th anniversary of EBMT, and the event gathered leading figures in the field of hematopoietic stem cell transplantation and over…
-
EBMT Hot Review | Professor Yang Liang: Beware of Invasive Fungal Diseases in Chronic Lymphocytic Leukemia Patients Treated with BTK Inhibitors
Patients with chronic lymphocytic leukemia (CLL) are susceptible to infections due to impaired humoral and cellular immunity. Bruton’s tyrosine kinase inhibitors (BTKi) are crucial in CLL treatment. Recent studies have shown an increased incidence of invasive fungal diseases (IFDs) (0.5% to 12.1%) in patients receiving BTKi treatment, particularly central nervous system infections. From April 14th…
-
Effects of genetic polymorphisms on methotrexat levels and toxicity in Chinese patients with acute lymphoblastic leukemia
In January 2023, a study led by Professor Jianxiang Wang from Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College was published…
-
Gene Therapy Milestone: Elevated FIX Levels Achieved in Chinese Hemophilia B Patients
In January 2023, Professor Jianmin Wang from Department of Hematology, Shanghai Changhai Hospital published a commentary on Blood Science. The title of the study is “Big stride in gene therapy for hemophilia B in China”. This article reviewed the development of treatment of hemophilia B (HB) in China, and the translational potential of gene therapy…
-
Hematopoietic stem cell heterogeneity in non-human primates revealed by five-lineage output bias analysis
In January 2023, a study led by Professor Bing Liu from Fifth Medical Center, Medical Innovation Research Department, Chinese PLA General Hospital was published in the international academic journal ——Blood Science . The title of the study is “Hematopoietic stem cell heterogeneity in non-human primates revealed by five-lineage output bias analysis”. This study elucidates the…
Connecting Medical Expertise through Media
